Community Rehabilitation Service Support Centre
Kowloon, Hong Kong
NCT Number: NCT05159635
The objective of this study is to evaluate the effectiveness of adopting a home-use Wearable Technical Aids (WTA) with the structured Active Living Program (ALP) to promote community participation in young stroke patients.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Kowloon, Hong Kong
Two groups of patients would receive Wearable Technical Aids Training or Wearable Technical Aids Training and structured Active Living Program (ALP) for 8 sessions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-diagnosed with foot drop with tibialis anterior muscle strength between 1 to 3- out of 5 in manual muscle testing for more than six months due to cerebrovascular accident (CVA)
Exclusion criteria
attend 6 weeks active living programme and apply wearable technical aids for 8 weeks.
apply wearable technical aids for 8 weeks.
Time frame: before intervention, 8 weeks (after intervention )
The quality of life scale for the people with stroke
Time frame: before intervention,8 weeks (after intervention)
10 meters walk time
Kowloon Hospital, Hong Kong
Other
The Effectiveness of Combining Active Living Programme (ALP) With Home-Use Wearable Technical Aids (WTA) to Promote Community Participation in Young Stroke With Foot Drop Problem- The Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06539247
Brain Diseases, Cardiovascular Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT02483676
Brain Diseases, Cardiovascular Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT02693834
Brain Diseases, CVA
Frisco, Texas, United States
View Trial DetailsNCT00148343
Brain Diseases, Cardiovascular Diseases
Cleveland, Ohio, United States
View Trial Details